s6y
Company name or ticker
Search
Sunshine Biopharma Inc.
DRS
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filed
Tuesday, April 28, 2026
Accession number
0001683168-26-003259
Documents
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRS
Exhibits
10.19
Material contract
EX-10.19
On sec.gov
Filing index
All files
Complete submission text
SGML header